HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.

AbstractBACKGROUND:
Antibodies to the cysteine-rich domain II of Plasmodium vivax Duffy binding protein (PvDBP) can inhibit binding of this parasite ligand to its receptor on red blood cells, the Duffy antigen/receptor for chemokines. These binding-inhibitory antibodies (BIAbs) also inhibit P. vivax invasion of reticulocytes in vitro.
METHODS:
To investigate whether naturally acquired anti-PvDBP antibodies are associated with reduced risk of clinical malaria in a population exposed to low levels of P. vivax transmission, we measured total levels of immunoglobulin G antibodies to 5 PvDBP variants and used a functional in vitro assay to quantify their binding-inhibitory activity in a cohort of 466 rural Amazonians followed up for up to 37 months.
RESULTS:
No association between total immunoglobulin G antibody responses to any PvDBP variant and risk of symptomatic, laboratory-confirmed vivax malaria was observed in this cohort. However, a Cox proportional hazards model, adjusted for age, sex, and genotype for the Duffy antigen/receptor for chemokines, showed a >40% decrease in the prospective risk of clinical vivax malaria in subjects with the strongest BIAb responses (upper and middle terciles). High BIAb responses were mostly PvDBP variant transcending and stable over time.
CONCLUSIONS:
Strong naturally acquired BIAb responses are associated with a reduced risk of clinical P. vivax malaria in rural Amazonians.
AuthorsVanessa C Nicolete, Sarah Frischmann, Susana Barbosa, Christopher L King, Marcelo U Ferreira
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 214 Issue 10 Pg. 1539-1546 (11 15 2016) ISSN: 1537-6613 [Electronic] United States
PMID27578850 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail [email protected].
Chemical References
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Duffy antigen binding protein, Plasmodium
  • Immunoglobulin G
  • Protozoan Proteins
  • Receptors, Cell Surface
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Protozoan (blood)
  • Antigens, Protozoan (immunology)
  • Brazil
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Infant
  • Malaria, Vivax (immunology, prevention & control)
  • Male
  • Middle Aged
  • Plasmodium vivax (immunology)
  • Prospective Studies
  • Protozoan Proteins (immunology)
  • Receptors, Cell Surface (immunology)
  • Rural Population
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: